Abstract
The intrauterine contraceptive device (IUD) is an establshed method of fertility regulation despite certain problems. The major problems relating to IUD use are unwanted pregnancy, excessive bleeding, genital infection, occasional uterine perforation, device translocation, and pelvic pain. All fertility regulation personnel are aware that a very large number of potential IUD acceptors are concerned about the possibility of pain before, during and after device insertion.
Pain is recognized as one of the major reasons for termination of the use of the IUD. Despite this, and unlike other IUD problems, IUD-related pain has been very poorly studied. At a recent workshop on intrauterine contraception there was not one presentation on this topic [1]. The reason for this is that IUD-related pain is difficult to study, requiring careful analysis of subjective rather than objective data. Nevertheless a thorough understanding of the mechanisms, causes, prevention and treatment of IUD-related pain is important for fertility regulators in both developed and developing countries.
Resumé
Malgré certains problèmes, la pose d'un dispositif contraceptif inter-utérin (DIU) est une méthode établie de régulation de la fertilité. Les principaux problèmes liés à l'utilisation des DIU sont les suivants: grossesses involontaires, saignements excessifs, infections génitales, parfois perforations utérines, déplacement du dispositif et douleurs pelviennes. Les responsables de la régulation de la fertilité sont tous conscients du fait qu'un très grand nombre de femmes qui accepterainent éventuellement d'utiliser un DIU sont préoccupées par la possibilité de douleurs avant, pendant et après la mise en place d'un dispositif.
Il est admis que l'abandon d'un DIU est déterminé dans la plupart des cas par les doulers qu'il occasionne. Pourtant, au contraire d'autres problèmes liés aux DIU, les douleurs qu'ils peuvent causer ont été fort peu étudiées. A des journées de travail sur la contraception interutérine tenues récemment, aucune communication à ce sujet n'a été présentée [1]. Cette lacune provient de ce qu'il est difficile de mener une étude sur les douleurs liées à l'utilisation des DIU, celle-ci nécessitant une analyse de données subjectives plutôt qu'objectives. Il est néanmoins essentiel, pour les responsables de la régulation de la fertilité, aussi bien dans les pays développés que dans les pays en développement, de compre à fond les mécanismes, les causes, la prévention et le traitement des douleurs liées à l'utilisation des DIU.
Resumen
Pese a ciertos problemas, el dispositivo anticonceptivo intrauterino (DIU) es un método reconocido para la regulación de la fertilidad. Los mayores problemas relacionados con el uso de DIU son: embarazo no deseado, sangrado excesivo, infección genital, perforación uterina ocasional, dispositivo cambiado de sitio y dolor pelviano. El personal que regula la fertilidad tiene conciencia que a un gran número de potenciales aceptantes de DIU les preocupa la posibilidad de dolor antes, durante y después de la inserción del dispositivo.
El dolor está reconocido como una de las mayores razones para la terminación del uso de DIU. Pese a esto, y a diferencia con otros problemas conectados con los DIU, el dolor relacionado con ellos ha sido muy poco estudiado. En una reciente reunión de trabajo sobre anticoncepción intrauterina, no hubo ninguna presentación sobre este tópico [1]. La razón de esto es que el dolor relacionado con los DIU es difícil de estudiar y requiere un cuidadoso análisis de datos subjetivos más que objetivos. Sin embargo, la comprensión absoluta del mecanismo, las causas, la prevención y el tratamiento del dolor relacionado con los DIU es importante para la regulación de la fertilidad, tanto en los países desarrollados como en aquellos en desarrollo.
Similar content being viewed by others
References
ZatuchniG. I., GoldsmithA. and SciarraJ. J., eds. (1985).Intrauterine Contraception-Advances and Future Prospects. Proceedings of an International Workshop on Intrauterine Contraception, May 29–June 1, 1984, Harper and Row, Philadelphia
RenaerM. (1981).Chronic Pelvic Pain in Women. Springer-Verlag, Berlin, p. 4
GoldstuckN. D. (1979). The management of intrauterine device related pain.Br. J. Fam. Plann.,5, 63–65
SnyderS. H. (1979). Opiate receptors and internal opiates.Sci. Am.,236(3), 44–56
DawoodM. Y. (1985). Dysmenorrhoea.J. Reprod. Med.,30, 154–167
YlikorkalaO. and DawoodM. Y. (1978). New concepts in dysmenorrhoea.Am. J. Obstet. Gynecol.,130, 833–847
LaatikainenT., RaisanenI., TulenkeimoA., et al. (1985). Plasma β-endorphin and the menstrual cycle.Fertil. Steril.,44, 206–209
StrömbergP., AkerlundM., ForslingM. L., et al. (1984). Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhoea.Acta. Obstet. Gynecol. Scand.,63, 533–538
YenS. S. C., QuigleyM. E., ReidR. L., et al. (1985). Neuroendocrinology of opioid peptides and their role in the control of gonadotrophin and prolactin secretion.Am. J. Obstet. Gynecol.,152, 485–493
NewtonJ. R. and ReadingA. E. (1977). The effects of psychological preparation on pain at intrauterine device insertion.Contraception,16, 523–536
ReadingA. E., ReedC. and NewtonJ. R. (1979). A card sort method for pain assessment in gynaecology: a multi-dimensional approach.Acta. Obstet. Gynecol. Scand.,58, 105–113
Discussion, IUCD Workshop, London (1982).Br. J. Obstet. Gynaecol., Suppl. 4, 18–19
ElsteinM. (1982). IUCD liability.Br. J. Obstet. Gynaecol, Suppl.4, 11–17
GrahamS. and SimcockB. W. (1982). A review of the use of intrauterine devices in nulliparous women.Contraception,26, 323–346
WhiteM. K., OryH. W., RooksJ. B., et al. (1980). Intrauterine device termination rates and the menstrual cycle day of insertion.Obstet. Gynecol.,55, 220–224
GoldstuckN. D. (1979). Insertion of intrauterine devices. Some technical considerations.Practitioner,223, 647–651
GoldstuckN. D. and MatthewsM. L. (1985). A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device.Clin. Reprod. Fertil.,3, 65–71
GoldstuckN. D. (1985). Clinical uterine measuring techniques and their relevance to IUCD choice and performance.Br. J. Sex. Med.,12, 8–10
GoldstuckN. D. (1981). A comparison of the initial pain response following insertion of the Copper 7 and Combined Multiload 250-short IUDs.Contracept. Deliv. Syst.,2, 295–301
GoldstuckN. D. and MatthewsM. L. (1985). A comparison of the actual and expected pain response following removal of an IUCD.Adv. Contracept. Deliv. Syst.,1, 122–125
GoldstuckN. D. and WardP. J. (1983). Treatment of pain following IUD insertion with Meptazinol-a new centrally acting analgesic.Contracept. Deliv. Syst.,4, 33–37
GuillebandJ. and BoundsW. (1983). Control of pain associated with intrauterine device insertion using mefenamic acid.Res. Clin. Forum,5, 69–73
HassonH. M. (1977). Topical uterine anaesthesia — a preliminary report.Int. J. Gynaecol. Obstet.,15, 238–240
HassonH. M. (1984). Topical uterine anaesthesia for IUD insertion. In:Biomedical Aspects of IUDs, H. M.Hasson, W. A. A.vanOs and E. S. E.Hafez, eds., MTP Press, Lancaster, UK, pp. 89–97
HepburnS. (1980). Method of local anaesthesia for IUD insertion.Contracept. Deliv. Syst.,1, 371–382
KurzK. H. and Meier-OelkeP. (1983). Jet injection-local anaesthesia for fitting and removal of IUDs.Contracept. Deliv. Syst.,4, 27–32
LippesJ., MalikT. and TatumH. J. (1976). The post-coital Copper-T.Adv. Plann. Parent.,11, 24–29
SnowdenR. (1982). General assessment of the multiload Cu250 intrauterine device. UK network of IUCD research clinics.Br. J. Obstet. Gynaecol., Suppl. 4, 58–65
ButtramV., IzuA. and HenzlM. R. (1979). Naproxen sodium in uterine pain following intrauterine device insertion.Am. J. Obstet. Gynecol.,134, 575–581
MasseyS. E., VaradyJ. C. and HenzlM. R. (1974). Pain relief with Naproxen following insertion of an intrauterine device.J. Reprod. Med.,13, 226–231
RoyS. and ShawS. T. (1981). Role of prostaglandins in IUD associated uterine bleeding: Effect of a prostaglandin synthetase inhibitor (ibuprofen).Obstet. Gynecol.,58, 101–106
ReadingA. E. and GoldstuckN. D. (1981). The influence of clinic factors on IUD continuation.Eugen. Bull.,13, 117–124
ReadingA. E. and GoldstuckN. D. (1982). Effect of clinic related factors on continuation rates of IUDs.Contracept. Deliv. Syst.,3, 1–9
GoldstuckN. D. (1981). Pain response following insertion of a Gravigard (Copper 7) intrauterine contraceptive device in nulliparous women.Int. J. Fertil.,26, 53–56
AbdallaM. I., IbrahimI. I. and BayadM. A. (1985). Hysterographic uterine measurements and clinical endocrinologic implications. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds, Harper and Row, Philadelphia, p. 163
AbdallaM. I., KamalI., OsmanM. I., et al. (1981). Dimensional and architectural disproportion between the IUD and the uterine cavity: a cause of complications.Contracept. Deliv. Syst.,2, 31–35
KamalI. (1979). Atlas of hysterographic studies of the ‘IUD-holding uterus’. Mode of action and evaluation of size effects on intrauterine contraception. International Research Centre, Ottawa, Canada, p. 23
KurzK. H. (1981). Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.Contracept. Deliv. Syst.,2, 21–29
LuukkainenT., AllonenM., NygrenK. G., et al. (1985). Five years' experience with the Nova-T and T-Cu IUDs. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds., Harper and Row, Philadelphia, p. 79
PoppL. (1985). X-Ray and ultrasound in IUD management. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds., Harper and Row, Philadelphia, p. 232
TejujaS. and MalkaniP. K. (1969). Clinical significance of correlation between size of uterine cavity and IUD: a study by planimeter-hysterogram technique.Am. J. Obstet. Gynecol.,105, 620–627
YlikorkalaO., KauppilaA. and SiljanderM. (1978). Antiprostaglandin therapy in prevention of side effects of intrauterine contraceptive devices.Lancet,2, 393–395
RubinA. (1972). Complications due to Lippes Loop. Report of a death and other complications seen over an 18-month period at Baragwanath Hospital.South Afr. J. Obstet. Gynaecol.,10, 45–48
ZakinD., SternW. Z. and RosenblattR. (1981). Complete and partial uterine perforation and embedding following insertion of intrauterine devices. I. Classification, complications, mechanism, incidence and missing string.Obstet. Gynecol. Surv.,36, 335–353
ReadingA. E. and NewtonJ. R. (1977). A comparison of primary dysmenorrhoea and intrauterine device related pain.Pain,3, 265–276
HaukkamaaM., AllonenM., HeikilaM., et al. (1985). Long-term clinical experience with levonorgestrel releasing IUD. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds., Harper and Row, Philadelphia, p. 232
PizzarroP., Gomez-RogersC. and RoweP. J. (1979). Comparative study of the effect of Progestasert and Gravigard IUDs on dysmenorrhoea.Contraception,20, 455–466
TroboughG., GuderianA. M., EricksonR. R., et al. (1978). The effect of exogenous intrauterine progesterone on the amount and prostaglandin F2-α content of menstrual blood in dysmenorrhoeic women.J. Reprod. Med.,21, 153–156
BergerG. S., EdelmanD. A. and RegenieS. A. (1976). Patients' response to IUD insertion.Int. J. Obstet. Gynaecol.,14, 147–152
HagerW. D., EschenbachD. A., SpenceM. R., et al. (1983). Criteria for diagnosis and grading of salpingitis.Obstet. Gynecol.,61, 113–114
LedgerW. (1983). Diagnosis and treatment of salpingitis.J. Reprod. Med.,28(10S), 709–711
SweetR. L. (1981). Pelvic inflammatory disase: etiology, diagnosis and treatment.Sex. Transm. Dis.,8 (Suppl. 4), 308–315
GoldstuckN. D. (1982). The IUCD in nulliparous women: with special reference to the Multiload Copper 259 ‘mini’ and short IUCDs.Br. J. Obstet. Gynaecol., Suppl. 4, 54–57
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goldstuck, N.D. Pain reduction during and after insertion of an intrauterine contraceptive device. Adv Contracept 3, 25–36 (1987). https://doi.org/10.1007/BF01849250
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01849250